Hyperoxidized PRDX3 as a specific ferroptosis marker is a research paper published in Life Metabolism (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the University of Texas MD Anderson Cancer Center
Grant: R01CA181196, R01CA244144, R01CA247992, R01CA269646 and U54CA274220
the University of Texas MD Anderson Cancer Center
Grant: RP230072
the University of Texas MD Anderson Cancer Center
Grant: P30 CA016672
NCI NIH HHS
Grant: R01 CA181196
NCI NIH HHS
Grant: R01 CA269646
NCI NIH HHS
Grant: R01 CA244144
NCI NIH HHS
Grant: R01 CA247992
NCI NIH HHS
Grant: U54 CA274220
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R01CA244144-05
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation
National Institutes of Health
Grant: 5R01CA269646-03
Targeting ferroptosis in cancer therapy
National Institutes of Health
Grant: 5R01CA247992-05
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation
National Institutes of Health
Grant: 5R01CA181196-09
Studying metabolic stress signaling in renal cancer
National Institutes of Health
Grant: 1U54CA274220-01
Acquired Resistance to Therapy and Iron (ARTI) Center
Fields of Study
Keywords